Related Experiment Video
Updated: Jan 7, 2026

07:20
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
37.1K
Biomarkers
Minwoo Han1,2, Saehyun Kim2, Wooseok Jung2
1University of Ulsan College of Medicine, Seoul, Seoul, Korea, Republic of (South).
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 24, 2025
Summary
A deep learning model was developed to automatically detect lacunes, which are associated with cognitive decline. The model showed promising results in identifying lacunes on MRI scans, aiding in the diagnosis of neurological conditions.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Medical Diagnostics
Background:
- Lacunes, often of vascular origin, are linked to cognitive decline and amyloid-related imaging abnormalities (ARIA).
- Accurate lacune detection is crucial for understanding neurological disease progression.
- Distinguishing lacunes from mimicking features in imbalanced datasets presents a significant challenge.
Purpose of the Study:
- To develop a deep learning model for automated lacune segmentation.
- To enhance the model's ability to differentiate true lacunes from similar-appearing lesions.
- To address the challenge of imbalanced datasets in lacune detection.
Main Methods:
- Utilized 427 T2-FLAIR MRI images for model development.
- Employed an Attention U-Net architecture with an encoder pre-trained using supervised contrastive learning.
- Evaluated instance-level detection using AFROC analysis and patient-level outcomes via AUC.
Main Results:
- The model achieved a figure-of-merit (FOM) of 0.726 for instance-level lacune detection.
- Patient-level AUC for lacune detection was 0.810.
- Demonstrated moderate sensitivity in identifying patients with varying lacune counts (1-2 lacunes or 3+ lacunes).
Conclusions:
- A deep learning approach effectively detects lacunes in imbalanced datasets.
- Supervised contrastive learning pre-training enhances model performance.
- Future research will focus on regional lacune localization and multi-center external validation.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

